The US President Donald trump on Tuesday, may 26, announced the plan, which will significantly reduce the cost of insulin for American seniors who rely on Medicare.
According to the White house counsel Kellyann Conway, the deal signed with the national insulin manufacturers and providers of medical services would limit the fee for a one-month supply of insulin up to $35, representing a 66% reduction in operating costs.
The initiative will be extended to every third participant of the Medicare program, which diabetes and about 3 million people.
The decision followed the rumors about the rising cost of insulin in the United States. In 2019, the man died after switching to a cheaper version of insulin, to help pay for my wedding.
“More predictable costs for expenses will help seniors to fulfill the recommendation of doctors, “says Conway.
The initiative will be announced during the event in the Rose garden of the White house with the participation of trump and health managers of the country.
The plan, which came into force in January 2021, will save seniors approximately 56%, or an average of $446 per year, says Seema Verma, administrator of the Centers for Medicare and Medicaid Services.